RAPAMYCIN: CAN THIS DRUG SLOW AGING? I’ve noticed rapamycin being mentioned in numerous articles from outlets like National Geographic, NPR, and AARP. The buzz surrounding this drug centers on its potential to slow the aging process. Rapamycin, initially approved by the FDA as an immunosuppressant to prevent organ transplant rejection, functions by modulating the immune system and decreasing inflammation. Now, researchers are exploring its broader applications, particularly as a possible intervention to delay aging and improve health span. Seeking a concise update on the latest developments, I came across an article by Graham Lawton on NewScientist.com titled Rapamycin is a...